Cisplatin Injection, Solution
Product Images NDC 68083-162

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisplatin (NDC 68083-162). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cisplatin-100ml-carton-label (100ml Carton Label)

Packaging label for CISPLATIN Injection 100 mg/100 mL (1 mg/mL) intravenous solution by Gland Pharma Limited. The 100 mL multiple dose vial contains 1 mg cisplatin per mL with sodium chloride and pH adjusters. The label includes warnings about dosage limits, storage instructions, and a barcode, along with NDC 68083-163-01.*

FDA Label Image

Cisplatin-100ml-vial-label (100ml Vial Label)

Label for CISplatin Injection 100 mg/100 mL (1 mg/mL) solution for intravenous use, manufactured by Gland Pharma Limited. The label indicates it is a cytotoxic agent in a 100 mL multiple-dose vial. It includes composition details, storage instructions, and a barcode. The label also features a warning about dosing frequency and a space for lot and expiration dates.*

FDA Label Image

Cisplatin-50ml-carton-label (50ml Carton Label)

Packaging label for CISPLATIN Injection 50 mg/50 mL (1 mg/mL) solution for intravenous use, labeled as a cytotoxic agent. The label indicates a 50 mL multiple dose vial manufactured by Gland Pharma Limited. It includes warnings about verifying drug name and dose, and notes that cisplatin doses greater than 100 mg/m² once every 3 to 4 weeks are rarely used.*

FDA Label Image

Cisplatin-50ml-vial (50ml Vial Label)

CISplatin Injection 50 mg/50 mL (1 mg/mL) vial label for intravenous use by Gland Pharma Limited. This label includes strength, dosage form, multiple dose vial indication, cytotoxic agent warning, storage instructions, and manufacturer information with lot and expiry coding area. The label also cautions that doses greater than 100 mg/m² every 3 to 4 weeks are rarely used and refers to the package insert for details.*

FDA Label Image

Cispaltinimage01 (Cisplatin01)

Chemical structure diagram of the active ingredient Cisplatin, showing a platinum (Pt) atom bonded to two ammine (NH3) groups and two chloride (Cl) atoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.